Literature DB >> 12367555

Expression of transgene encoded TGF-beta in islets prevents autoimmune diabetes in NOD mice by a local mechanism.

Iqbal S Grewal1, Kate D Grewal, F Susan Wong, Hua Wang, Dominic E Picarella, Charles A Janeway, Richard A Flavell.   

Abstract

To analyse the effects of TGF-beta in insulin dependent diabetes mellitus (IDDM), we have developed non-obese diabetic (NOD) transgenic mice expressing TGF-beta under the control of the rat insulin II promoter. Pancreata of TGF-beta transgenic mice were roughly one twentieth of the size of pancreata of wild-type NOD mice and showed small clusters of micro-islets rather than normal adult islets. However, these islets produced sufficient levels of insulin to maintain normal glucose levels and mice were protected from the diabetes, which developed in their negative littermates. A massive fibrosis was seen in the transgenic pancreata that was accompanied with infiltration of mononuclear cells that decreased with age. Interestingly, these mice showed normal anti-islet immune response in their spleens and remained susceptible to adoptive transfer of IDDM by mature cloned CD8 effector cells. TUNEL assays revealed increased apoptosis of invading cells when compared to non-transgenic NOD mice. Taken together, these results suggest that TGF-beta protects islets by a local event.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12367555     DOI: 10.1006/jaut.2002.0599

Source DB:  PubMed          Journal:  J Autoimmun        ISSN: 0896-8411            Impact factor:   7.094


  30 in total

Review 1.  TGF-beta, T-cell tolerance and anti-CD3 therapy.

Authors:  Ramireddy Bommireddy; Thomas Doetschman
Journal:  Trends Mol Med       Date:  2004-01       Impact factor: 11.951

2.  Transgenic expression of TGF-beta on thyrocytes inhibits development of spontaneous autoimmune thyroiditis and increases regulatory T cells in thyroids of NOD.H-2h4 mice.

Authors:  Shiguang Yu; Yujiang Fang; Gordon C Sharp; Helen Braley-Mullen
Journal:  J Immunol       Date:  2010-03-24       Impact factor: 5.422

3.  Retroviral Foxp3 gene transfer ameliorates liver granuloma pathology in Schistosoma mansoni infected mice.

Authors:  Kameshwar P Singh; Herve C Gerard; Alan P Hudson; Thipparthi R Reddy; Dov L Boros
Journal:  Immunology       Date:  2005-03       Impact factor: 7.397

4.  Emerging roles for the TGFbeta family in pancreatic beta-cell homeostasis.

Authors:  Melissa L Brown; Alan L Schneyer
Journal:  Trends Endocrinol Metab       Date:  2010-04-08       Impact factor: 12.015

Review 5.  Targeting regulatory T cells in the treatment of type 1 diabetes mellitus.

Authors:  S M Cabrera; M R Rigby; R G Mirmira
Journal:  Curr Mol Med       Date:  2012-12       Impact factor: 2.222

6.  TGF-beta regulates in vivo expansion of Foxp3-expressing CD4+CD25+ regulatory T cells responsible for protection against diabetes.

Authors:  Yufeng Peng; Yasmina Laouar; Ming O Li; E Allison Green; Richard A Flavell
Journal:  Proc Natl Acad Sci U S A       Date:  2004-03-18       Impact factor: 11.205

7.  Highly purified Th17 cells from BDC2.5NOD mice convert into Th1-like cells in NOD/SCID recipient mice.

Authors:  David Bending; Hugo De la Peña; Marc Veldhoen; Jenny M Phillips; Catherine Uyttenhove; Brigitta Stockinger; Anne Cooke
Journal:  J Clin Invest       Date:  2009-02-02       Impact factor: 14.808

8.  Auricular chondritis in NOD.DQ8.Abetao (Ag7-/-) transgenic mice resembles human relapsing polychondritis.

Authors:  Veena Taneja; Marie Griffiths; Marshall Behrens; Harvinder S Luthra; Chella S David
Journal:  J Clin Invest       Date:  2003-12       Impact factor: 14.808

Review 9.  TGFbeta1 and Treg cells: alliance for tolerance.

Authors:  Ramireddy Bommireddy; Thomas Doetschman
Journal:  Trends Mol Med       Date:  2007-10-30       Impact factor: 11.951

Review 10.  Neutralization Versus Reinforcement of Proinflammatory Cytokines to Arrest Autoimmunity in Type 1 Diabetes.

Authors:  Ayelet Kaminitz; Shifra Ash; Nadir Askenasy
Journal:  Clin Rev Allergy Immunol       Date:  2017-06       Impact factor: 8.667

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.